MedPath

Sedation Regimen in Patients Undergoing Cardiac Electrophysiology Study and Ablation : a Comparison Between Dexmedetomidine-remifentanil and Midazolam-remifentanil Combinations

Not Applicable
Completed
Conditions
Cardiac Arrhythmia
Interventions
Drug: dexmedetomidine-remifentanil
Drug: midazolam-remifentanil
Registration Number
NCT01652586
Lead Sponsor
Yonsei University
Brief Summary

Cardiac ablation is an invasive procedure requiring anesthetic support for immobility and analgesia. Benzodiazepines and opioids are the most commonly used agents, while they are associated with respiratory depression and hypotension. The aim of this study was to compare the effect of remifentanil and dexmedetomidine, which exerts sedative and analgesic effect without serious respiratory depression, with conventional midazolam/remifentanil combination on sedative and analgesic levels in patients undergoing endocardial ablation.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
90
Inclusion Criteria
  • patients scheduled for elective cardiac ablation for atrial fibrillation
Exclusion Criteria
  • ASA physical status class ≥ 3,
  • respiratory disease,
  • end stage renal disease,
  • illiterate

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
dexmedetomidine-remifentanildexmedetomidine-remifentanilintravenous infusion of 0.2-0.7 µg/kg/h of dexmedetomidine after a loading dose of 1 µg/kg over 10 min
midazolam-remifentanilmidazolam-remifentanilremifentanil 3.6-7.2 mcg/kg/h midazolam 1-2mg
Primary Outcome Measures
NameTimeMethod
change of sedation depth5 min after study drug adminstration, and every 10 min thereafter

1. Ramsay sedation score (1 = anxious and agitated, restless; 2 = cooperative, oriented, tranquil; 3 = responsive to verbal commands, drowsy; 4 = asleep, responsive to light stimulation; 5 = asleep, slow response to stimulation; 6 = no response to stimulation)

2. the bispectral index

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath